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Background: Type I DNA topoisomerases, divided
mechanistically into two subfamilies, are ubiquitous
enzymes that participate in replication and transcription.
In addition to its role in these fundamental processes, the
biological importance of eukaryotic DNA topoisomerase
I is underscored by its identification as the target of the
antitumor alkaloid camptothecin. An understanding of
the mechanism of catalysis and interactions with camp-
tothecin and other drugs has been hampered by a lack of
detailed structural information.
Results: The three-dimensional structure of a 26 kDa
fragment (residues 135 to about 363) of Saccharomyces
cerevisiae DNA topoisomerase I has been determined at
1.9 A resolution. The fragment has a novel architecture
comprising a concave platform and a pair of outlying
V-shaped helices. Photocrosslinking and protein foot-
printing experiments show that the positively charged
concave surface and the junction region of the V-shaped
pair of helices contact DNA in the enzyme-DNA
complex.
Conclusions: Crystallographic, biochemical and genetic
data indicate that this 26 kDa fragment of yeast DNA
topoisomerase I is involved in complex formation
between the enzyme and DNA, and probably also in
camptothecin-enzyme-DNA ternary complex formation.
A molecular model for protein-DNA interaction based
on these data is proposed. The bipartite DNA-binding
regions of the 26 kDa fragment may enable eukaryotic
DNA topoisomerase I to adapt to sequence-dependent
structural variations in its DNA substrates.
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Introduction
DNA topoisomerases catalyze topological transforma-
tions of DNA rings via successive trans-esterification
reactions [1]. Type I DNA topoisomerases, which effect
such transformations through the transient breakage of
one DNA strand and the passage of another strand
through the broken strand before its resealing, can be
classified into two subfamilies. One subfamily, which
includes Escherichia coli DNA topoisomerases I and III
and yeast DNA topoisomerase III, preferentially relaxes
negatively supercoiled DNA, forms a 5' phosphotyrosine
linkage in the enzyme-DNA covalent intermediate, and
has high affinity for single-stranded DNA [2]. The other
subfamily, which includes eukaryotic DNA topo-
isomerase I, poxviral topoisomerases [3], and probably
topoisomerase V of the thermophile Methanopyrus kand-
leri [4], relaxes both positively and negatively supercoiled
DNA, forms a 3' phosphotyrosine linkage in the
enzyme-DNA covalent intermediate, and prefers double-
stranded DNA substrates [2]. Eukaryotic DNA topoiso-
merase I is a ubiquitous enzyme that participates in a
number of key cellular processes including transcription,
replication, and recombination [5]. Interests in this type
of enzyme have been further stimulated as a result of its
identification as the target of the antitumor alkaloid
camptothecin [6].
The three-dimensional structure of a 67 kDa N-terminal
fragment of E. coli DNA topoisomerase I has been
determined at 2.2 A resolution [7]. Both structural and
biochemical data support an enzyme-bridging mechanism
of DNA strand passage by this enzyme (i.e. the enzyme
interacts with both sides of the transiently broken DNA
strand in its catalysis of DNA strand passage [2,7]). By
contrast, structural information for the eukaryotic DNA
topoisomerase I subfamily of enzymes is scarce. A 9 kDa
N-terminal fragment of the vaccinia virus topoisomerase
was recently solved at 1.6 A [8]. However, the lack of sig-
nificant sequence homology between this region of the
viral enzyme and eukaryotic DNA topoisomerase I makes
it difficult to extend the results from the former to the lat-
ter [8,9]. We therefore crystallized and solved the struc-
ture of a 26 kDa fragment of yeast DNA topoisomerase I
comprising residues 135 to about 363. The fragment has a
novel architecture which, in combination with photo-
crosslinking and protein footprinting results, leads to a
model for the binding of this fragment to DNA.
Results and discussion
Crystallization and structure determination
The 26 kDa fragment of Saccharomyces cerevisiae DNA
topoisomerase I comprises residues 135 to about 363.
Deletion mutagenesis experiments have previously shown
that the N-terminal 135 amino acids of S. cerevisiae DNA
topoisomerase I are not required for relaxation activity
in vitro. Complementation experiments in E. coli have
shown that S. cerevisiae DNA topoisomerase I can
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substitute for E. coli DNA topoisomerase I function in
vivo. However, in these experiments the N-terminal 135
amino acids of S. cerevisiae DNA topoisomerase I are nec-
essary for in vivo complementation of the E. coli enzyme.
Larger deletions of the yeast enzyme extending into the
26 kDa fragment abolish enzymatic activity in vitro and in
vivo [10]. The 26 kDa fragment was obtained by prote-
olytic treatments of an overexpressed polypeptide (as
described in the Materials and methods section), and was
found to crystallize in both tetragonal and orthorhombic
crystal forms. The crystal structure of the orthorhombic
form was solved to 2.8 A by multiple isomorphous
replacement (MIR) and refined to 1.9 A (Tables 1,2).
The structure of the tetragonal form was solved by mol-
ecular replacement to 3.0 A (Tables 1,2); overall the
structure in the two crystals forms is similar, although
there are significant differences (root mean square
deviation [rmsd] of 0.8 A for all Cot atoms; see below).
Architecture and electrostatics
The 26 kDa fragment forms a platform with a concave
surface on one side. The platform consists of two
domains (I and II) linked by an extended polypeptide
stretch (PPI), and by a pair of outlying ot helices (C and
D) that are connected in the shape of a V (see Fig. la,b).
Domain I is formed by two antiparallel o helices (A and
Table 1. Data collection and MIR statistics.
Crystal
P2,2121 P212121 P2,2121
-170°C
47.20
53.07
116.89
26.3- 26.5- 39.0-
2.5 4.0 1.85
10722 2060 24425
62572 6596 127777
98.1 72.5 95.1
(89.5) (74.9) (80.1)
6.4 5.0 6.4
(15.4) (4.8) (27.8)
36.5 11.9 -
Space group
Temperature
Dimensions (A)
a
b
C
Resolution
range (A)
Reflections
unique
total
Completeness
(%)
sym
MFIDt
MIRAS analysis
(20-2.8 A)
Number of sites
Phasing power*
acentric
centric
Rc§
Mean FOM #
acentric
centric
P4212
RT
153.9
153.9
39.16
42.6-
2.94
8859
20584
80.3
(21.4)
7.8
(34.1)
*R sym= I-<l> /I, where I=observed intensity, and <I>=average
intensity obtained from multiple measurements. *MFID (mean
fractional isomorphous difference)=N F, I-Fpj I/'IFp , where
Fp and Fph are the protein and heavy-atom derivative structure
factor amplitudes, respectively. t Phasing power=rms(jFh /E), where
Fh =heavy-atom structure-factor amplitude and E=residual lack
of closure error. Rc= IFh(obs - Fh(calc IA I/ Fh(obsi for centric
reflections where I Fh(obsl) an IFh(Cal cI are the observed and
calculated heavy-atom structure-factor amplitudes, respectively.
#FOM, figure of merit. **Numbers in parentheses designate values for
the highest resolution shell.
Native I Hg Pt Native II Native III
P212121
-1°C
48.06
53.58
118.01
34.2-
2.8
7521
17921
96.6
(95.5)**
6.3
(10.5)
- 1 2
- 1.2 0.9
- 1.0 0.7
0.83 0.90
0.34
0.42
B) lying against one side of a three-stranded antiparallel
13 sheet (S2, S3 ,S4). Helices A and B make hydrophobic
contacts with a long 3-hairpin-like loop (CL) that pro-
trudes from domain II. Both the N and C termini of the
fragment reside in domain II, which is made of two
13 sheets forming a distorted 13-barrel-like structure. The
'elbow' of the V-shaped ot helices (residues 252-254)
connecting domains I and II is disordered in both crystal
forms, suggesting an inherent flexibility. The PPI seg-
ment connecting domains I and II is proline-rich and
forms a left-handed polyproline helix of the type usually
found in mobile regions on protein surfaces [11]. The
presence of the disordered elbow and the polyproline
helix suggests that there may be some flexibility in the 26
kDa fragment and in the relative disposition of domains I
and II. This is supported by the observation that domain
I is virtually identical in both crystal forms (rmsd for Cot
atoms of 0.41 A), but domain II is more variable (rmsd
for Cot atoms of 0.76 A). Superimposing both domains
together reveals that the V-shaped helices differ the most
(rmsd for Cot atoms of 1.6 A).
The spatial disposition of domains I, II, and the CL loop
creates a concave surface with a curvature of approxi-
mately 30 A diameter on one side of the platform of the
26 kDa fragment, a curvature close to that observed in
other proteins that are known, or thought, to interact
with double-stranded DNA, such as E. coli DNA topoi-
somerase I [7], the DNA polymerase processivity factors
from E. coli. and S. cerevisiae [12,13], and the
TATA-binding protein [14,15]. Additionally, the concave
side has a total of 15 positively charged amino acids, 11
of which are highly conserved. These positive charges
create a strong positive electrostatic potential [16] that is
absent from the rest of the protein fragment (Fig. 2).
Photocrosslinking of the 26 kDa fragment to DNA
The 26 kDa fragment does not exhibit significant DNA-
binding activity in filter-binding or band-shift assays (data
Table 2. Refinement statistics.
Crystal form Orthorhombic Tetragonal
Resolution limits (A) 8-1.9 7-3.0
R-factor (%)* 22.2 20.4
Rfree (%)t 29.0 #
Number of amino acid residues 220 214
Number of water molecules 232 **
Rms bond length (A)* 0.014 0.015
Rms bond angle (o°) 1.73 3.0
Average B-factor (A2)§ 27.0 20.0
*R-factor is based on 90% of the native data set used in
refinement. tRfree is the R-factor based on 10% of the native
data withheld for the cross-validation test as implemented in
X-PLOR. *Root mean square deviation from ideal values for
bond lengths and angles. Average B-factor of all atoms in the
structure. #No Rfree evaluation was done for the tetragonal
data because the data set was incomplete. **No water
molecules were modeled into the tetragonal crystal form
because of the limiting resolution of native data.
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Fig. 1. Crystal structure of the 26 kDa S. cerevisiae DNA topoisomerase I fragment. (a) Ribbon diagram showing the overall architecture
of the fragment. The two domains are labeled as well as the secondary structural elements. a( helices are denoted A to D, strands SI
to S10. The polyproline helix joining domains I and II is labeled PPI; the loop extending from domain II into domain I is labeled CL.
(Drawn using MOLSCRIPT [32].) (b) Stereo drawing of the Ca backbone trace of the fragment. The view is perpendicular to (a), with
the two V-shaped at helices pointing away from the viewer, and with every 20th residue numbered. The dotted line denotes a break in
electron density for residues 252-254.
not shown), yet this portion of eukaryotic DNA topo-
isomerase I appears be be required for enzymatic activity.
To test the possibility that this domain is involved in
DNA binding in the intact enzyme, photocrosslinking
was carried out between a 3 2 P-labeled DNA fragment
containing a photoactivatable base (see the Materials and
methods section for details) [17] and a catalytically active
yeast enzyme immunotagged at its N terminus. The
product was first digested with staphylococcal nuclease to
remove the bulk of the DNA, partially trypsinized, pre-
cipitated with antibodies specific to the N-terminal
immunotag, and analyzed by SDS-PAGE. Figure 3a
shows that the C terminus of the smallest 32P-labeled
immunotagged fragment is near Cys23 2 , which is located
at the beginning of oa helix C and is well within the
26 kDa fragment. Thus, in the functional enzyme, the
26 kDa domain appears to contact DNA.
Fig. 2. Electrostatic potential map of the fragment. The surface of
the protein is shown with positively and negatively charged
residues shown in blue and red respectively. The grid surround-
ing the fragment corresponds to contours of positive (blue) and
negative (red) potential at ±2 KbT/e (where Kb is the Boltzmann
constant, T is the temperature, and e is the charge of the elec-
tron). This figure clearly shows the positive potential region
around one face of the protein. (Figure drawn with GRASP 33].)
Protein footprinting
To better define the nature of the interaction between
the 26 kDa fragment and DNA, we mapped the posi-
tions of lysine residues that are most probably involved in
binding DNA and thereby protected from modification
by citraconic anhydride [18]. Figure 3b shows that lysines
245, 248, 249, 256 and 257 in ao helices C and D, 286,
301, 304 and 306 in the CL loop, and 357 in domain II
are protected. The protected lysines are present on one
side of the 26 kDa fragment (shown in Fig. 4) in
both domains I and II and the V-shaped a helices. The
asymmetric distribution of lysine residues confers a
high positive electrostatic potential [16], appropriate for
interaction with negatively charged DNA.
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Fig. 3. Binding of the 26 kDa fragment to DNA. (a) Photo-
crosslinking of DNA and catalytically active yeast DNA topo-
isomerase I immunotagged at its N terminus. Lane 1,
photocrosslinking reaction products; lane 2, reaction products
digested with staphylococcal nuclease; lane 3, nuclease-treated
products after partial digestion with trypsin; lane 4, products of
mock immunoprecipitation in which the monoclonal antibody
against the N-terminal immunotag was omitted; lane 5, immuno-
precipitated peptides using monoclonal antibody directed
against the N-terminal epitope; lane 6, size markers (see Materi-
als and methods for details). (b) Detection of specific lysines in
yeast DNA topoisomerase I that are protected against citracony-
lation by DNA. Lanes 1 and 2 contained samples serving as
length markers; lane 1, immunotagged yeast DNA topoisomerase
I subjected to complete acetylation of lysine residues and partial
cleavage by cyanogen bromide, and lane 2 the same protein
subjected to complete acetylation and partial cleavage by
2-nitro-5-thiocyanatobenzoic acid. Lanes 3 and 4 contained
immunotagged yeast DNA topoisomerase I footprinted by the
two-step lysine-modification method [18] in the absence and
presence of DNA, as indicated at the top of the lanes.
Model for protein-DNA interaction
Considered together, the biochemical and crystal-
lographic data suggest a plausible model for interaction
between the 26 kDa fragment and DNA. DNA can be
docked onto the fragment such that the backbone
phosphates are close to the footprinted lysines. One face
of the DNA contacts two protein regions separated by
about 25 A (shown in Fig. 5a,b): one region includes
domain II and the CL loop; the second region includes
the distal part of the V-shaped ot helices. In this model,
the DNA lies in a region of positive electrostatic
potential. Because domains I and II are joined by two
potentially flexible regions (the V-shaped a helices and
the polyproline helix) small interdomain movements
may occur to improve the fit between the protein and
DNA or to accommodate local structural variations in
the DNA helix; relative displacements between the
outlying V-helices and the concave platform may serve
similar purposes.
Fig. 4. Footprinted lysine residues. Orthogonal views of the van
der Waals surface of the 26 kDa fragment in which all lysine and
arginine residues are in blue and have blue dotted surfaces, and
the side chains of lysines shown to interact with DNA by the pro-
tection experiments are in cyan with blue dotted surfaces. These
views show that the concave surface is lined with positively
charged residues.
Drug-resistant mutants
In the model shown, the CL loop is also in close
proximity to DNA. Biochemical studies have identified
two mutations in the N-terminal region of mammalian
DNA topoisomerase I that diminish camptothecin
sensitivity [19,20]. These mutations map to the CL loop
in the S. cerevisiae protein (Phe293 and Gly295). The
residues forming the CL loop are highly conserved
between yeast and mammalian DNA topoisomerase I.
Because camptothecin is known to stabilize the covalent
intermediate between DNA and eukaryotic DNA
topoisomerase I, the location of these mutations suggests
that the CL loop might be near the active site and may
participate in camptothecin binding as well as in DNA
cleavage and rejoining.
Comparison with other type I enzymes
The very high amino acid sequence similarity (>50%) [9]
among enzymes of the eukaryotic DNA topoisomerase I
type implies a strong structural conservation. It is very
likely that the two-domain architecture, the 3 hairpin
loop (CL), the V-shaped (x helices, and the asymmetric
charge distribution are general characteristics of all
enzymes of this subfamily rather than specific features of
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Fig. 5. Model for the possible interac-
tion of DNA with the 26 kDa fragment
of S. cerevisiae DNA topoisomerase I
based on structural and biochemical
data. (a) A B-DNA molecule (in gold)
was modeled to lie on the concave side
of the protein and in the region of posi-
tive electrostatic potential. The 10 pro-
tected lysines (green), additional lysine
and arginine residues in the region
(blue) and Phe293 (one of the residues
involved in camptothecin resistance)
(red) are in close proximity to the mod-
eled DNA. The lysines are shown in the
conformations observed in the crystal
structure; local adjustments are likely
when the enzyme interacts with DNA.
(Drawn using SETOR [341.) (b) Surface
drawing of the protein showing the
good fit of the DNA to the concave side
of the structure. The E-carbon and
amino group of lysines that are pro-
tected from citraconylation by DNA are
highlighted in green. Residues affecting
camptothecin resistance when mutated
are highlighted in red. (Drawn with
GRASP 1331.)
the yeast enzyme. The 26 kDa yeast topoisomerase I
fragment shows no structural similarity to the 67 kDa
N-terminal fragment of E. coli DNA topoisomerase I [7],
a member of a separate subfamily of type I DNA topo-
isomerases. A comparison of the structure of the 26 kDa
fragment with that of a 9 kDa N-terminal fragment of
vaccinia virus topoisomerase [8] also shows that they are
structurally distinct.
Biological implications
Eukaryotic DNA topoisomerase I is a ubiquitous
enzyme that participates in transcription, replica-
tion and recombination [5]. It is also the target of
the antitumor alkaloid camptothecin [6]. A com-
bined crystallographic and biochemical analysis of
a 26 kDa fragment (residues 135 to about 363) of
yeast DNA topoisomerase I indicates that this
domain is involved in DNA-protein complex for-
mation and probably in camptothecin-enzyme-
DNA interactions as well.
Interaction with DNA occurs on one surface of
the fragment that has a strong positive electro-
static potential, suggesting the importance of
electrostatic forces in the interaction. Two sepa-
rate regions of the 26 kDa fragment are involved
in DNA binding, and a comparison of the struc-
ture in two different crystal forms suggests that
there is some conformational flexibility within
and between the two DNA-binding regions. This
flexibility may facilitate interactions between the
enzyme and DNA substrates of different
sequences or conformations.
Two amino acid residues have been identified in
human DNA topoisomerase I (equivalent to
Phe293 and Gly295 in the yeast 26 kDa fragment)
that confer camptothecin resistance when mutated
[19,20]. These residues map to a loop that consti-
tutes part of the DNA-binding surface. Because
the drug is thought to stabilize the covalent pro-
tein-DNA intermediate, it is plausible that this
loop may be near the active site for DNA cleavage
and rejoining.
Materials and methods
Protein expression, purification and crystallization
A 45 kDa recombinant protein consisting of the first 383
amino acids of yeast DNA topoisomerase I plus a nonapeptide
immunotag at its N terminus was overexpressed in yeast and
purified. The purified protein was subjected to partial proteoly-
sis with subtilisin to yield a 35 kDa protein with ThrlOl as its
N terminus. This was further proteolyzed by chymotrypsin to
yield a stable 26 kDa fragment with Glu135 at its N terminus.
The 26 kDa protein was purified and stored at 40C at a con-
centration of 10-20 mg ml-' in 10 mM Hepes (pH 7.5),
30 mM KCI. Orthorhombic crystals of the 26 kDa fragment
were grown by vapor diffusion at 180C against 20% PEG 3350,
0.1 M Tris-HCl (pH 8.0). Typical orthorhombic crystals are
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75 x 75 x 250 pxm3 in size. Tetragonal crystals were grown from
the same precipitant plus 0.4 M ammonium sulfate; macroseed-
ing significantly improved the size of these crystals [211.
Data collection
Diffraction data from both crystal forms were collected using a
Xentronics/Siemens area detector [22]. Orthorhombic crystals
were cooled to -10 C for data collection; data for the tetragonal
crystals were collected at room temperature. All data were
processed using the programs XDS and XSCALE [23,24].
High-resolution, cryo-cooled native data were collected at the
Stanford Synchrotron Radiation Laboratory using the MAR
imaging plate system. For cryo-cooling, single orthorhombic
crystals were transferred over a period of 6 min to 18% sorbitol
plus mother liquor in 6% steps. Crystals were scooped out
using rayon loops and flash frozen in a -1700C nitrogen
stream. Data for cryo-cooled crystals were indexed and
reduced using the program DENZO [25]. All subsequent data
processing was done using the CCP4 suite [26]. Statistics are
summarized in Table 1.
Heavy-atom derivatives and phasing
Orthorhombic crystals were soaked in 2 mM mercuric acetate
for 8 days, and in 10 mM K2PtCI 6 for 36 h. Several derivatives
were tried but these two heavy-atom compounds gave the
most interpretable difference Patterson maps. The position of
the single mercury site was determined from difference Patter-
son and anomalous difference Patterson maps. The phases cal-
culated from this derivative were used to locate the two
platinum sites by difference Fourier synthesis. MLPHARE [27]
was used for heavy-atom refinement and phasing.
Model building and refinement of the orthorhombic
crystal form
An MIR map from data between 10 A and 2.8 A was
&arculated and improved by several cycles of solvent flattening
[26]. A Ca trace was built using the BONES option of O [28];
[3 strands and a helices were discernible in the starting map.
The model was broken into four discontinuous polyalanine
segments containing a total of 187 residues; all residues with
ambiguous densities and connectivities were left out of this
initial model. Model refinement of the fragment was done with
the program X-PLOR [29]. Five rounds of positional
refinement were carried out against native data in the range of
10-2.8 A. The starting R-factor was 44.5% and the Rfree was
54.7%. The Rfree evaluation test was used throughout the
course of the refinement as a measure of the correctness of the
model [30]. Combined model and MIR phases were calculated
using SIGMAA [26] and new electron-density maps calculated.
These combined maps were used to thoroughly rebuild the
initial model. After several cycles of rebuilding and refinement,
side chains and residues were added to the model, further
reducing the R-factor to 31.2% and the Rfree to 46.4%. At this
stage there were 199 residues in total, in three segments.
However, the model refined no further, probably due to the
weakness of the native data set. A new native data set was
collected at SSRL using cryo-cooled protein crystals. Rigid-
body refinement of the protein model against the cryo-cooled
data in the resolution range of 8-4 A gave an initial R-factor of
31% and an Rfree of 34.1% (the set of test reflections was
different for each data set). This was followed by simulated
annealing slow-cool refinement (5-2.8 A) [29] which reduced
the R-factor to 26.3% and increased the Rfree to 36.3%.
Extensive model rebuilding was done using 2Fo-F c and Fo-Fc
electron-density maps. Side chains and residues were added,
and a total of 220 residues were finally modeled into the elec-
tron density. As the refinement started to converge, and once
the R-factor was below 25%, water molecules were added
using the water-pekpik option of O. The native data were cor-
rected for anisotropic temperature factors using the 'baoverall'
option of X-PLOR. The model was checked periodically
using the program PROCHECK [31], and outliers fixed.
Finally, individual atomic temperature factors were refined.
The final model was confirmed by a series of simulated
annealing omit maps (Fig. 6a), which were computed by
sequentially omitting from the structure a sphere, every
twentieth residue, of 8 A. The final R-factor for data between
8-1.9 A is 22.2% with an Rfree of 29.0%. There are 220
residues in the model and 232 water molecules. The main-
chain density in 2Fo-Fc maps, an example of which is shown in
Figure 6, is broken at the intersection of the two V-shaped
a( helices, and therefore residues 252-254 have not been
Fig. 6. Electron-density maps. (a) Simu-
lated annealing omit map. The 1.9 A
map was calculated by removing all
atoms inside an 8 A sphere centered on
residue 210. Similar maps were calcu-
lated covering the whole molecule to
assess the quality of the structure. Con-
tours correspond to the 0.95c level.
(b) A 2Fo-F map contoured at the
2.25(r level showing the region around
residue 210.
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modeled (dotted lines in Fig. b). The stereochemical quality
of the final model is excellent, with an rmsd from ideality in
bond lengths of 0.014 A, and in angles of 1.73 °. The average
temperature factor for all atoms is 27 A2 and there are no
outliers in the Ramachandran plot.
Refinement of the tetragonal crystal form
The tetragonal crystal form of the same fragment was solved
primarily to confirm the model derived from the orthorhombic
crystal form. This was done using an intermediate model of the
orthorhombic crystal form. The initial solution for the rotation
and translation functions gave an R-factor of 48.3% and a cor-
relation coefficient of 0.47 using the program AMoRe [26].
Rigid-body refinement of this solution reduced the R-factor
to 46.1% and gave a correlation coefficient of 0.55. At this
stage the lattice packing of the model was checked, and a few
residues from the N and C termini which could sterically clash
with symmetry-related molecules were removed. Several cycles
of positional refinement using X-PLOR were done in the res-
olution range of 7-3 A, without modeling any water mol-
ecules, leading to an R-factor of 20.4%. The coordinates of the
orthorhombic crystal model are being deposited in the
Brookhaven Protein Data Bank.
Photocrosslinking
DNA with one 20 nucleotide strand and one 14 nucleotide
strand recessed at its 3'-end was used as the substrate for repair
synthesis by the Klenow fragment of E. coli DNA polymerase I.
Triphosphates of a photoreactive nucleotide 5-[N-(p-azidoben-
zoyl)-3-aminoallyl]-deoxyuridine [17] and c(x-32 P-deoxy-
adenosine were used in the repair of the 5'-TsA overhang. A
catalytically active yeast DNA topoisomerase I derivative, with
an 11-residue phage T7 gene 10 peptide fused to amino acids
139-769 of yeast DNA topoisomerase I, was overproduced and
purified from E. coli. The immunotagged enzyme (18 g) and
labeled DNA (1.6 g) were incubated in 100 pl of a buffer
containing 20 mM Tris-HCI, pH 8.0, 50 mM KCI, 1 mM
2-mercaptoethanol, 10% (v/v) glycerol, and 100 ig of bovine
serum albumin as a carrier protein. Following UV irradiation,
CaCl2 was added to a final concentration of 1 mM and the
mixture was digested with 1 unit of staphylococcal nuclease
(Boehringer Mannheim, Indianapolis, IN) at room temperature
for 10 min. Nuclease digestion was terminated by the addition
of EGTA to 10 mM. Following incubation with trypsin
(10 ng) for 20 min at 30°C, the partially trypsinized products
were immunoprecipitated using a monoclonal antibody
directed against the T7 gene 10 epitope (Novagen, Madison,
WI). Immunoprecipitated polypeptides that became radio-
labeled by their crosslinking to DNA were visualized by
autoradiography following SDS-PAGE. Aliquots of the
reaction mixtures were sampled at various steps for comparison
with the immunoprecipitated final products. Size markers (lane
6, Fig. 3a) were prepared by partial cleavage of immunotagged
yeast DNA topoisomerase I with 2-nitro-5-thiocyanatobenzoic
acid (which cleaves at cysteine residues), followed by fractiona-
tion on the same polyacrylamide gel, and immunochemical
visualization.
Protein footprinting
The chemical footprinting reactions employing citraconic
anhydride, N-hydroxysuccinimide, and endoproteinase Lys-C,
were carried out using the immunotagged yeast DNA topoiso-
merase I as previously described [18] except that, after treat-
ment with citraconic anhydride, the reaction mixture was
diluted with three volumes of 8 M guanidine hydrochloride
before the acetylation reaction.
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